Top Markets
#1 CyberDEX CyberDEX +678.13%
#2 GEKKO GEKKO +21.15%
#3 Harmony Harmony +20.18%
#4 龙虾 (Lobster) 龙虾 (Lobster) +16.62%
#5 DogBull DogBull +13.32%
#6 DexNet DexNet +12.63%
#7 Arweave Arweave +11.79%
#8 LayerZero LayerZero +11.43%
#9 Stargate Finance Stargate Finance +11.32%
#10 Backpack Backpack +10.34%
Coin of the day
CyberDEX CyberDEX
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Abbott Laboratories Abbott Laboratories

Abbott Laboratories

ABT
Kedudukan dalam Saham #118
Abbott Laboratories, along with its affiliated entities, is a global healthcare... Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
Harga Saham
$97.46
Disegerakkan terakhir: 2026-10-02
Modal Pasaran
$168.63B
Perubahan (1 hari)
0.77%
Perubahan (1 tahun)
-27.59%
Negara
US
Perdagangan Abbott Laboratories (ABT)

Kategori

Healthcare
Hasil untuk Abbott Laboratories (ABT)
Hasil pada Jun 2026 TTM: $46.59B
Menurut laporan kewangan terkini daripada Abbott Laboratories, hasil semasa syarikat (TTM) ialah $46.59B. Pada tahun 2024, syarikat memperoleh hasil sebanyak $41.95B peningkatan berbanding hasil pada tahun 2023 iaitu $40.11B. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Abbott Laboratories dari 2000 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
2026 (TTM) $46.59B 5.09%
2025 $44.33B 5.67%
2024 $41.95B 4.59%
2023 $40.11B -8.12%
2022 $43.65B 1.34%
2021 $43.08B 24.47%
2020 $34.61B 8.48%
2019 $31.90B 4.34%
2018 $30.58B 11.64%
2017 $27.39B 31.35%
2016 $20.85B 2.20%
2015 $20.41B 0.78%
2014 $20.25B -7.33%
2013 $21.85B -45.21%
2012 $39.87B 2.63%
2011 $38.85B 10.48%
2010 $35.17B 14.31%
2009 $30.77B 4.19%
2008 $29.53B 13.94%
2007 $25.91B 15.30%
2006 $22.48B 0.62%
2005 $22.34B 13.51%
2004 $19.68B 0.00%
2003 $19.68B 11.29%
2002 $17.68B 8.59%
2001 $16.29B 18.47%
2000 $13.75B 0.00%
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -23.83%
IE
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -44.54%
US
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -54.93%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -86.02%
US